Complete financial analysis of Clever Leaves Holdings Inc. (CLVR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Clever Leaves Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- DTE Energy Company 2021 Series (DTG) Income Statement Analysis – Financial Results
- Capital Gearing Trust p.l.c (CGT.L) Income Statement Analysis – Financial Results
- Hunt Companies Acquisition Corp. I (HTAQ-WT) Income Statement Analysis – Financial Results
- Poenina Holding AG (PNHO.SW) Income Statement Analysis – Financial Results
- DigitalBridge Group, Inc. (6CL.F) Income Statement Analysis – Financial Results
Clever Leaves Holdings Inc. (CLVR)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cleverleaves.com
About Clever Leaves Holdings Inc.
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 17.42M | 17.80M | 15.37M | 12.12M | 7.83M | 0.00 |
| Cost of Revenue | 10.86M | 13.47M | 8.57M | 4.70M | 4.73M | 99.00K |
| Gross Profit | 6.56M | 4.33M | 6.81M | 7.41M | 3.10M | -99.00K |
| Gross Profit Ratio | 37.64% | 24.33% | 44.29% | 61.18% | 39.60% | 0.00% |
| Research & Development | 1.14M | 1.72M | 1.55M | 1.01M | 0.00 | 0.00 |
| General & Administrative | 17.99M | 27.82M | 38.40M | 29.83M | 34.98M | 4.75M |
| Selling & Marketing | 2.04M | 1.90M | 3.80M | 2.58M | 3.18M | 417.00K |
| SG&A | 20.03M | 29.71M | 42.19M | 32.41M | 38.16M | 5.31M |
| Other Expenses | 0.00 | 2.06M | 1.77M | 1.85M | 1.48M | 0.00 |
| Operating Expenses | 21.17M | 33.49M | 45.51M | 34.26M | 39.64M | 5.31M |
| Cost & Expenses | 33.01M | 46.96M | 54.07M | 38.96M | 44.37M | 5.41M |
| Interest Income | 0.00 | 2.70M | 6.82M | 4.46M | 2.68M | 390.00K |
| Interest Expense | 46.00K | 2.70M | 6.82M | 4.46M | 2.68M | 0.00 |
| Depreciation & Amortization | 2.85M | 3.67M | 3.51M | 3.59M | 1.48M | 99.00K |
| EBITDA | -16.84M | -35.80M | -35.19M | -23.26M | -41.72M | -5.31M |
| EBITDA Ratio | -96.66% | -144.33% | -225.63% | -203.91% | -454.35% | 0.00% |
| Operating Income | -15.59M | -29.16M | -38.70M | -26.85M | -36.54M | -5.41M |
| Operating Income Ratio | -89.53% | -163.82% | -251.72% | -221.56% | -466.43% | 0.00% |
| Total Other Income/Expenses | -4.14M | -15.00M | -5.98M | 951.00K | -9.34M | 13.15M |
| Income Before Tax | -19.73M | -72.46M | -44.68M | -36.68M | -45.88M | 7.74M |
| Income Before Tax Ratio | -113.27% | -407.05% | -290.63% | -302.67% | -585.70% | 0.00% |
| Income Tax Expense | 68.00K | -6.35M | 950.00K | 4.74M | 2.25M | -126.00K |
| Net Income | -17.90M | -66.10M | -45.63M | -41.41M | -48.13M | 7.36M |
| Net Income Ratio | -102.77% | -371.35% | -296.81% | -341.78% | -614.37% | 0.00% |
| EPS | -11.42 | -51.65 | -53.29 | -49.93 | -184.77 | 0.00 |
| EPS Diluted | -11.42 | -51.65 | -53.29 | -49.93 | -184.77 | 0.00 |
| Weighted Avg Shares Out | 1.57M | 1.28M | 856.34K | 829.43K | 260.49K | 0.00 |
| Weighted Avg Shares Out (Dil) | 1.57M | 1.28M | 856.34K | 829.43K | 260.49K | 0.00 |
Clever Leaves Announces Voluntary Delisting and SEC Deregistration
TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, today announced that its Board of Directors (the “Board”) determined to voluntarily delist its common...
Clever Leaves Reports Fourth Quarter and Full Year 2023 Results
- 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue - - Drove Year-over-Year General and Administrative Expense Reductions of 26% in Q4 2023 and 24% for the Full Year - - Completed Sale of Non-Cannabinoid...
High Growth: Top Pot Stocks Making Moves into March 2024
As the cannabis industry continues to flourish in the United States, investors are keenly watching the market for top-performing marijuana stocks. With the industry projected to reach a staggering $30 billion by 2025, the allure of double-digit gains before March...
Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia
TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced today that through its partnership with award-winning Dutch seed bank, Paradise Seeds (“Paradise”), to...
Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)
Multinational operator has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products.
Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of Investors
SAN DIEGO--(BUSINESS WIRE)---- $CLVR #CleverLeavesHoldingsInc--Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of Investors.
Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of Shareholder
SAN DIEGO--(BUSINESS WIRE)---- $CLVR #CleverLeavesHoldingsInc--Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of Shareholder.
Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
NEW YORK--(BUSINESS WIRE)---- $CLVR #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“Schultze”), which merged with Clever Leaves Holdings Inc. (“Clever Leaves”) (NASDAQ:...
Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
NEW YORK--(BUSINESS WIRE)---- $CLVR #classaction--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“Schultze”), which merged with Clever Leaves Holdings Inc. (“Clever Leaves”)...
Clever Leaves Holdings, Inc. (CLVR) Q3 2023 Earnings Call Transcript
Clever Leaves Holdings, Inc. (NASDAQ:CLVR ) Q3 2023 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Jackie Keshner - Director of Investor Relations Andres Fajardo - Chief Executive Officer Hank Hague - Chief Financial Officer Conference Call...
Source: https://incomestatements.info
Category: Stock Reports